294 related articles for article (PubMed ID: 35883467)
41. C-terminal modulators of heat shock protein of 90 kDa (HSP90): State of development and modes of action.
Bickel D; Gohlke H
Bioorg Med Chem; 2019 Nov; 27(21):115080. PubMed ID: 31519378
[TBL] [Abstract][Full Text] [Related]
42. A small molecule cell-impermeant Hsp90 antagonist inhibits tumor cell motility and invasion.
Tsutsumi S; Scroggins B; Koga F; Lee MJ; Trepel J; Felts S; Carreras C; Neckers L
Oncogene; 2008 Apr; 27(17):2478-87. PubMed ID: 17968312
[TBL] [Abstract][Full Text] [Related]
43. Inhibitors of the HSP90 molecular chaperone: current status.
Sharp S; Workman P
Adv Cancer Res; 2006; 95():323-48. PubMed ID: 16860662
[TBL] [Abstract][Full Text] [Related]
44. The heat shock protein 90 chaperone complex: an evolving therapeutic target.
Barginear MF; Van Poznak C; Rosen N; Modi S; Hudis CA; Budman DR
Curr Cancer Drug Targets; 2008 Sep; 8(6):522-32. PubMed ID: 18781898
[TBL] [Abstract][Full Text] [Related]
45. Integration of the accelerator Aha1 in the Hsp90 co-chaperone cycle.
Li J; Richter K; Reinstein J; Buchner J
Nat Struct Mol Biol; 2013 Mar; 20(3):326-31. PubMed ID: 23396352
[TBL] [Abstract][Full Text] [Related]
46. Targeting the molecular chaperone heat shock protein 90 (HSP90): lessons learned and future directions.
Hong DS; Banerji U; Tavana B; George GC; Aaron J; Kurzrock R
Cancer Treat Rev; 2013 Jun; 39(4):375-87. PubMed ID: 23199899
[TBL] [Abstract][Full Text] [Related]
47. The cellular world according to Hsp90.
Richter K; Hendershot LM; Freeman BC
Nat Struct Mol Biol; 2007 Feb; 14(2):90-4. PubMed ID: 17277798
[TBL] [Abstract][Full Text] [Related]
48. Role of HSP90 in Cancer.
Birbo B; Madu EE; Madu CO; Jain A; Lu Y
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638658
[TBL] [Abstract][Full Text] [Related]
49. The Hsp90 complex--a super-chaperone machine as a novel drug target.
Scheibel T; Buchner J
Biochem Pharmacol; 1998 Sep; 56(6):675-82. PubMed ID: 9751071
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of cancer invasion and metastasis by targeting the molecular chaperone heat-shock protein 90.
Koga F; Kihara K; Neckers L
Anticancer Res; 2009 Mar; 29(3):797-807. PubMed ID: 19414312
[TBL] [Abstract][Full Text] [Related]
51. Discovery of novel Hsp90 C-terminal domain inhibitors that disrupt co-chaperone binding.
Mak OW; Sharma N; Reynisson J; Leung IKH
Bioorg Med Chem Lett; 2021 Apr; 38():127857. PubMed ID: 33609661
[TBL] [Abstract][Full Text] [Related]
52. The HSP90 chaperone machinery.
Schopf FH; Biebl MM; Buchner J
Nat Rev Mol Cell Biol; 2017 Jun; 18(6):345-360. PubMed ID: 28429788
[TBL] [Abstract][Full Text] [Related]
53. Targeting chaperones in transformed systems--a focus on Hsp90 and cancer.
Chiosis G
Expert Opin Ther Targets; 2006 Feb; 10(1):37-50. PubMed ID: 16441227
[TBL] [Abstract][Full Text] [Related]
54. Combination of Anti-Cancer Drugs with Molecular Chaperone Inhibitors.
Shevtsov M; Multhoff G; Mikhaylova E; Shibata A; Guzhova I; Margulis B
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31652993
[TBL] [Abstract][Full Text] [Related]
55. Hsp90 Chaperones Bluetongue Virus Proteins and Prevents Proteasomal Degradation.
Mohl BP; Roy P
J Virol; 2019 Oct; 93(20):. PubMed ID: 31375577
[TBL] [Abstract][Full Text] [Related]
56. Hsp90 isoforms: functions, expression and clinical importance.
Sreedhar AS; Kalmár E; Csermely P; Shen YF
FEBS Lett; 2004 Mar; 562(1-3):11-5. PubMed ID: 15069952
[TBL] [Abstract][Full Text] [Related]
57. Targeting HSP70: the second potentially druggable heat shock protein and molecular chaperone?
Powers MV; Jones K; Barillari C; Westwood I; van Montfort RL; Workman P
Cell Cycle; 2010 Apr; 9(8):1542-50. PubMed ID: 20372081
[TBL] [Abstract][Full Text] [Related]
58. Constantly updated knowledge of Hsp90.
Terasawa K; Minami M; Minami Y
J Biochem; 2005 Apr; 137(4):443-7. PubMed ID: 15858167
[TBL] [Abstract][Full Text] [Related]
59. Cucurbitacin D Is a Disruptor of the HSP90 Chaperone Machinery.
Hall JA; Seedarala S; Rice N; Kopel L; Halaweish F; Blagg BS
J Nat Prod; 2015 Apr; 78(4):873-9. PubMed ID: 25756299
[TBL] [Abstract][Full Text] [Related]
60. Targeting Hsp90 and its co-chaperones to treat Alzheimer's disease.
Blair LJ; Sabbagh JJ; Dickey CA
Expert Opin Ther Targets; 2014 Oct; 18(10):1219-32. PubMed ID: 25069659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
